Cathie Wood's position in 10x Genomics is currently worth $175 Million. That's 1.43% of their equity portfolio (22nd largest holding). The investor owns 5.71% of the outstanding 10x Genomics stock. The first 10x Genomics trade was made in Q2 2020. Since then Cathie Wood bought shares eight more times and sold shares on seven occasions. The investor's estimated purchase price is $643 Million, resulting in a loss of 73%.
The U.S. spends approximately $450 billion every year treating rare diseases. Investing guru Cathie Wood says managing patients afflicted with these illnesse...
InvestorPlace, about 2 months agoCathie Wood’s ARK Invest (NYSEARCA: ARKK ) fund sold $40 million in Coinbase (NASDAQ: COIN ) stock as the crypto exchange hit a 20-month high. Since Dec. 5, ...
InvestorPlace, 4 months agoHere''s why our roundtable likes 10x Genomics, Beam Therapeutics, and Recursion Pharmaceuticals.
The Motley Fool, almost 2 years ago